• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

dishonesty

  1. Way to go Uncle NO

    FDA ready to crack down as Novartis reveals manipulated Zolgensma data
    • anonymous
    • Thread
    • crooks dishonesty non-patient focus
    • Replies: 1
    • Forum: Novartis
Top Bottom
Back